May 6, 2020 / 11:58 AM / 19 days ago

BRIEF-Rocket Pharmaceuticals Reports Q1 Loss Per Share $0.45

May 6 (Reuters) - Rocket Pharmaceuticals Inc:

* ROCKET PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND HIGHLIGHTS RECENT PROGRESS

* Q1 LOSS PER SHARE $0.45

* Q1 EARNINGS PER SHARE ESTIMATE $-0.49 — REFINITIV IBES DATA

* STRONG BALANCE SHEET WITH $275.9 MILLION IN CASH, CAPITALIZED INTO 2022

* CASH POSITION. CASH, CASH EQUIVALENTS AND INVESTMENTS AS OF MARCH 31, 2020, WERE $275.9 MILLION

* ROCKET EXPECTS SUCH RESOURCES WILL BE SUFFICIENT TO FUND ITS OPERATIONS INTO 2022

* Q1 EARNINGS PER SHARE VIEW $-0.49 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below